Clinical Trial Update: Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating guselkumab for hidradenitis suppurativa focusing on mode of action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED